Investigational Multi-Drug Resistant Tuberculosis drug Bedaquiline gets backing from FDA panel
Johnson & Johnson said that the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) ruled that its experimental treatment for multidrug-resistant tuberculosis appears to be More...